Way Towards New Life

Multiple Sclerosis Medications

Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.

Get access to an unapproved drug for personal use.

Here is a list of some of the Multiple Sclerosis Medications for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

OCREVUS (ocrelizumab) injection

OCREVUS is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis.

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Query Form

We would love to speak with you.
Feel free to reach out using the below details.

Get Access to an Unapproved Drug

Get access to an unapproved drug for personal use to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.